Ajanta Pharma features among ‘Forbes Asia’s 200 Best corporations under a Billion’

02 Sep 2013 Evaluate

Ajanta Pharma , a specialty focused pharmaceutical formulation company, featured among the 'Forbes Asia's 200 Best under a Billion' list consecutively for the second year.

It is indeed an important moment, as the company's efforts have been recognized by a leading publication of world repute consistently for past 2 years as one of the best performing companies in Asia under a billion dollars. Only 19 Indian companies from various industries have been able to make to this prestigious compilation, including Ajanta.

Forbes Asia's editors maintain a database of 15,000 stock-traded companies in Asia-Pacific region with revenues between $5 million and $1 billion. 873 companies were short listed and finally the top 200 companies were finalized. Only 52 companies from the last year's list have re-qualified this year. Based on 3 stringent criteria of return on equity, growth in sales and earnings & debt-equity ratio, they selected 200 best performing companies and Ajanta is proud to be one amongst this elite list.

Ajanta Pharma is engaged manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.

Ajanta Pharma Share Price

2274.00 -58.90 (-2.52%)
03-Jun-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1455.00
Dr. Reddys Lab 5792.95
Cipla 1459.85
Zydus Lifesciences 1035.95
Lupin 1589.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.